Showing 201-210 of 648 results for "".
Radiologic Differential Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-differential-diagnosis-of-multiple-sclerosis/54601/This article provides an overview of the radiographic features that are shared and those that are distinct among multiple sclerosis, aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte protein antibody–associated disease.An Algorithmic Approach to Headache With Fever
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-algorithmic-approach-to-headache-with-fever/54600/Headache accompanied by fever can indicate a wide range of disorders, making prompt and comprehensive evaluation crucial to identify the underlying cause and guide appropriate management for better patient outcomes.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.Brain Health & Dementia Risk Reduction
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/brain-health-dementia-risk-reduction/31540/As preventative neurology becomes possible, it is worth providing risk reduction care to those at risk of Alzheimer’s disease dementia.Neural Antibodies as Diagnostic Biomarkers of Autoimmune Encephalitis and Inflammatory Demyelinating Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neural-antibodies-as-diagnostic-biomarkers-of-autoimmune-encephalitis-and-inflammatory-demyelinating-disease/32103/Neural antibodies are diagnostic biomarkers of autoimmune encephalitis, NMOSD, and MOGAD.- What to Expect When the MS Patient is Expectinghttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0708MSPregFea-pdf/31007/Multiple sclerosis (MS) typically manifests in individuals during their late 20s, with an average onset age of 28 for women and early 30s for men. Relapsing-remitting MS is the most prevalent form, predominantly affecting females, while primary progressive MS shows equal incidence across genders. Re
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0807-dementia-pdf/31134/Recent advancements in Alzheimer’s disease (AD) research are prompting a reevaluation of the traditional amyloid-beta (Aβ) hypothesis. Historically, the focus has been on Aβ42 as the primary pathogenic species driving AD, with Aβ40 considered less harmful. However, emerging studies suggest a more nu
Dementia Insights:
Short- and Long-Term Cognitive Consequences of Acute Non-Neurological Hospitalizationhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-brshort--and-long-term-cognitive-consequences-of-acute-non-neurological-hospitalization/30786/Most neurologists are not surprised to hear that a patient has cognitively or physically deteriorated after hospitalization, but what is the evidence and mechanism for this?Diagnosis and Management of Sleep Disorders in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-sleep-disorders-in-individuals-with-parkinson-disease/37652/Common sleep disorders affecting people with Parkinson disease can be difficult to diagnose and require targeted treatments to optimize health, symptom management, and quality of life in this population.Neuropsychiatric Aspects of Alzheimer’s Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychiatric-aspects-of-alzheimers-disease/31538/Clinically significant neuropsychiatric symptoms need evidence-based treatment.